Literature DB >> 1597876

Lassa fever encephalopathy: clinical and laboratory findings.

D Cummins1, D Bennett, S P Fisher-Hoch, B Farrar, S J Machin, J B McCormick.   

Abstract

Clinical and laboratory findings are reported in nine patients who developed acute encephalopathy during the course of Lassa fever. The encephalopathy manifested 3-17 days after disease onset with confusion, followed rapidly by tremor (seven patients), grand mal convulsions (seven), abnormal posturing (three) and coma (eight); focal neurological signs and evidence of raised intracranial pressure were not seen. Eight patients died, most commonly from respiratory arrest following a protracted fit. Development of encephalopathy did not correlate with the presence of virus in cerebrospinal fluid (CSF), nor with virus antibodies in CSF and/or serum; thus, neither direct cytopathic nor immune-mediated mechanisms seem to be involved in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597876

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  23 in total

Review 1.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

2.  Is the brain spared in Crimean-Congo haemorrhagic fever? An MR-SWI study to reveal CNS involvement.

Authors:  Bilge Öztoprak; İbrahim Öztoprak; Aynur Engin
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

Review 3.  Progress in the experimental therapy of severe arenaviral infections.

Authors:  Brian B Gowen; Mike Bray
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

Review 4.  Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection.

Authors:  Wolfgang Löscher; Charles L Howe
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

5.  Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination.

Authors:  Anura Rambukkana; Stefan Kunz; Jenny Min; Kevin P Campbell; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

6.  Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.

Authors:  Danny A Asogun; Donatus I Adomeh; Jacqueline Ehimuan; Ikponmwonsa Odia; Meike Hass; Martin Gabriel; Stephan Olschläger; Beate Becker-Ziaja; Onikepe Folarin; Eric Phelan; Philomena E Ehiane; Veritas E Ifeh; Eghosasere A Uyigue; Yemisi T Oladapo; Ekene B Muoebonam; Osagie Osunde; Andrew Dongo; Peter O Okokhere; Sylvanus A Okogbenin; Mojeed Momoh; Sylvester O Alikah; Odigie C Akhuemokhan; Peter Imomeh; Maxy A C Odike; Stephen Gire; Kristian Andersen; Pardis C Sabeti; Christian T Happi; George O Akpede; Stephan Günther
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

7.  Pathogenesis of Lassa fever in cynomolgus macaques.

Authors:  Lisa E Hensley; Mark A Smith; Joan B Geisbert; Elizabeth A Fritz; Kathleen M Daddario-DiCaprio; Tom Larsen; Thomas W Geisbert
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

8.  International external quality assessment study for molecular detection of Lassa virus.

Authors:  Sergejs Nikisins; Toni Rieger; Pranav Patel; Rolf Müller; Stephan Günther; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2015-05-21

Review 9.  Sickness behaviour pushed too far--the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma.

Authors:  Ian A Clark; Alison C Budd; Lisa M Alleva
Journal:  Malar J       Date:  2008-10-14       Impact factor: 2.979

10.  Hospital-based surveillance for viral hemorrhagic fevers and hepatitides in Ghana.

Authors:  Joseph Humphrey Kofi Bonney; Mubarak Osei-Kwasi; Theophilus Korku Adiku; Jacob Samson Barnor; Robert Amesiya; Chrysantus Kubio; Lawson Ahadzie; Stephan Olschläger; Michaela Lelke; Beate Becker-Ziaja; Meike Pahlmann; Stephan Günther
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.